Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myxovirus Resistance Protein a and C-Reactive Protein-Guided Antimicrobial Treatment in Outpatients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease

NCT06779344 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT06779344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06779344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myxovirus Resistance Protein a and C-Reactive Protein-Guided Antimicrobial Treatment in Outpatients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Lead sponsor
Capital Medical University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 13, 2025
Completion date
December 31, 2026
Enrollment
458 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute exacerbation chronic obstructive pulmonary disease